|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| C07D 473/34 | (2006.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61K 31/52 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3303334 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16728566.7 |
| Date of filing the European patent application | 2016-06-02 | |
| (97) | Date of publication of the European application | 2018-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-02 |
| (46) | Date of publication of the claims translation | 2021-07-12 |
| (86) | Number | PCT/US2016/035588 |
| Date | 2016-06-02 |
| (87) | Number | WO 2016/196840 |
| Date | 2016-12-08 |
| (30) | Number | Date | Country code |
| 201562170547 P | 2015-06-03 | US | |
| 201562271689 P | 2015-12-28 | US |
| (72) |
GOLDSTEIN, David , US
OWENS, Timothy D. , US
|
| (73) |
Principia Biopharma Inc. ,
220 East Grand Avenue, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Tirozinkinazės inhibitoriai |
| TYROSINE KINASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2026-04-23 | 11 | 289.00 EUR |
| 2027-06-02 |